News
Another disappointing set of numbers - Q4 initial comment
Johan Sundén
Elvin Rolder
2026-02-20
09:06 CET
Overall impression. We believe few expected Q4 to be good quarter from BTS, yet the figures were once again underwhelming compared to our expectations. Sales were SEK710m, 2% below our expectation. Sales fell 5% organically Y/Y, a higher drop than we had expected, primarily driven by North America. EBITA was SEK86m, a full 23% below our forecast. However, the company took SEK10m in restructuring charges in Q4 related to the second phase of its efficiency initiatives. Thus, adj. EBITA was SEK96m, still 15% below our expectation, and down a full 30% Y/Y. Once again, weaker-than-expected earnings in North America drove the miss. The company writes that it expects Europe and Other markets to continue to deliver sales and earnings growth in 2026, and that they look forward to a return to growth for North America. In conjunction with this, it issued 2026 guidance that EBITA will be better than in 2025, which we believe should come as no surprise given the muted earnings in 2025 on lacklustre execution in the year. The board proposes a DPS of 4.4 (we estimated 4.52), down from 6.1 the year prior. OCF in Q4 was ~SEK210m (SEK222m in Q4 2024), driven by lower earnings Y/Y, and offset by a higher NWC release compared to last year. Reported net cash by end of Q4 was SEK46m.
Estimate changes. On the back of the Q4 numbers, we would expect another round of consensus cuts in the range 10–12%.
Share price reaction. The shares have been very weak in the past year, which has continued YTD. Although the company is optimistic for 2026 and confident in the turnaround of its largest division (North America), we believe the market will have a hard time buying it until this is shown in the numbers. Thus, we would expect a negative reaction in line with the expected revisions.